Drugs: how to pick a winner in clinical trials

26 Jun 2017

When a drug fails late on in clinical trials it’s a major setback for launching new medicines. It can cost millions, even billions, of research and development funds. Now, an ‘adaptive’ approach to clinical trials and a genetic tool for predicting success are increasing the odds of picking a winner. 

Read More
Elderly hands

Cambridge Drug Discovery Institute to fast-track development of new treatments for dementia

16 Feb 2015

Alzheimer’s Research UK, the world’s largest dedicated dementia research charity, has announced a £30 million Drug Discovery Alliance, launching three flagship Drug Discovery Institutes at the Universities of Cambridge, Oxford and UCL (University College London). The Drug Discovery Institutes will see 90 new research scientists employed in state-of-the-art facilities to fast-track the development of new treatments for Alzheimer’s disease and other dementias.

Read More
Brain lobes

AstraZeneca and University of Cambridge strengthen long-standing partnership

16 Oct 2014

AstraZeneca, its global biologics research and development arm, MedImmune, and the University of Cambridge today announce four new collaborations, building on their existing partnership. The latest collaborations reinforce AstraZeneca’s commitment to research in Cambridge following the company’s decision to locate one of its three global R&D centres and its global headquarters in the city that has been home to MedImmune’s biologics research laboratories for 25 years.

Read More

Public consultation on AstraZeneca plans

09 Jul 2014

Members of the local community have been invited to have their say on plans to build a new global research and development centre and corporate headquarters on the Cambridge Biomedical Campus.

Read More

Pages